Subcutaneous Infliximab Could Cut Jordan’s Autoimmune Disease Treatment Costs
A modeling study estimates that introducing subcutaneous infliximab in Jordan could save the payer millions of dollars over five years ...
A modeling study estimates that introducing subcutaneous infliximab in Jordan could save the payer millions of dollars over five years ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.